A Chinese patent medicine, Shexiang Baoxin Pill, for Non-ST-elevation acute coronary syndromes
A systematic review
Bibliographic Data
| ID | 14745338 |
|---|---|
| Authors | Zhou Zhou (0000-0001-9906-8889), Weixing Shen (0000-0002-6454-3296), Lili Yu (0000-0002-5378-3278), Cong Xu (0000-0002-8047-0488), Qibiao Wu (0000-0002-1670-1050) |
| Year | 2016 |
| Volume | 194 |
| Pages | 1130-1139 |
| Publication date | 2016-12-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Journal of Ethnopharmacology (JOURNAL) |
| Journal identifiers | ISSN: 0378-8741 • E-ISSN: 1872-7573 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.jep.2016.11.024 |
| Language | EN |
| Citations received | 3 |
| References cited | 19 |
Exploring the mechanism underlying the cardioprotective effect of shexiang baoxin pill on acute myocardial infarction rats by comprehensive metabolomics
Chemical compositions and pharmacological activities of natural musk (Moschus) and artificial musk
Quantitative proteomics reveals Shexiang Baoxin Pill exerts cardioprotective effects by preserving energy metabolism in a rat model of myocardial infarction
Heart Disease and Stroke Statistics—2013 Update
Preferred reporting items for systematic reviews and meta-analyses
Good practice in reviewing and publishing studies on herbal medicine, with special emphasis on traditional Chinese medicine and Chinese materia medica
Pharmacokinetics and tissue distribution of five bufadienolides from the Shexiang Baoxin pill following oral administration to mice
| Unique citing works | 3 |
|---|---|
| Citations per year | 0,5 |
| Citation span | 2020 - 2022 (3) |
| Citation velocity | historical |
| Highly cited | No |
| Citation types | Neutral: 3 |